Sitemap - 2024 - Trevor Klee’s Newsletter
Is longevity a choice? How about obesity?
The way scientists think about obesity now is wrong.
GLP-1 and GIP agonism and antagonism is weird
The twin mysteries of GLP-1 receptor agonists
Viking Therapeutics has an $8 billion market cap with 27 full time employees. This is their story.
When your family becomes inverse strangers
Karuna Therapeutics, a drug repurposing effort, sold for about $14 billion. This is their story.